Management of haemangioma neck using sclerosing agent- a case report

Bhadoria, S; Saxena, Rajat; Lavania, A

doi:10.3126/jcmsn.v8i1.6828

Cited by 2 publications

(2 citation statements)

References 6 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The results of the actual study were similar to the data of literature relating to sclerotherapy, with variations according to the type of sclerosing agent, its concentration, the number of injections, and the intervals between each treatment session [13, 14, 18, 24, 29, 30]. …”

Section: Discussionsupporting

confidence: 76%

Sclerotherapy of Intraoral Superficial Hemangioma

Abdyli

Perjuci

et al. 2016

Case Reports in Dentistry

View full text Add to dashboard Cite

Hemangioma is the clinical term for a benign vascular neoplasm due to proliferation of the endothelial lining of blood vessels. Their most frequent location is the body skin and oral mucosa. One of the treatment modalities for hemangiomas is intralesional injection of sclerosing agents which cause the damage of blood vessels followed by their obliteration. The objective of the study was to describe the facility of application and evaluate the efficiency of sclerotherapy with aethoxysklerol 1%. Method. The case presented with intraoral submucosal hemangioma of the cheek was treated by intralesional injection of aethoxysklerol 3% diluted in water for injections at a 4 : 1 ratio (0.75%) at the first appointment and 3 : 1 (1%) at the second appointment. The effect of sclerotherapy was evaluated on the following visits in time intervals of two weeks. Results. The hemangioma disappeared without complications after the second injection of aethoxysklerol 1%. The successful results of the study were comparable to the data of literature with variations according to the used sclerosant agent, its concentration, the number of injections, and the intervals between each session. Conclusion. Since sclerotherapy is a very effective, inexpensive, and easy-to-apply treatment, it should be the treatment of choice, especially for intraoral superficial hemangiomas.

show abstract

Section: Discussionsupporting

confidence: 76%

Sclerotherapy of Intraoral Superficial Hemangioma

Abdyli

Perjuci

et al. 2016

Case Reports in Dentistry

View full text Add to dashboard Cite

show abstract

“…3 Bhadoria et al have reported a case where they injected Polidocanol after diluting it with normal saline and observed regression with no complications. 10 In our study we did not dilute the drug.…”

Section: Discussionmentioning

confidence: 96%

Role of Polidocanol as Sclerosant in Treatment of Hemangiomas of Head and Neck Region

Sangma¹,

Patar²

2017

BJOHNS

View full text Add to dashboard Cite

Introduction Haemangiomas are common presentation in head and neck, prevalence being 60% followed by 25% and 15% respectively in trunk and limbs. This report studies the efficacy of Polidocanol as sclerosant in the treatment of heamangiomas in head and neck. Materials and Methods The two year prospective study conducted from January 2015 to December 2016 with Polidocanol as sclerosant on 55 patients attending the department of ENT. Intralesional injections of 3 % polidocanol were given at 2 week intervals. Results Out of 55 patients 15 cases did not follow up after the first dose, so results were calculated out of 40 patients. 12 patients showed complete regression & 15 showed regression to half the size. Thus 67.5 % patients showed acceptable results. There were no side effects except hyperpigmentation in 2 patients. There were no cases of recurrence during our study period. Conclusion Sclerotherapy is a promising method of treatment for haemangiomas of head and neck that may obviate the need for surgical intervention.

show abstract

Management of haemangioma neck using sclerosing agent- a case report

Cited by 2 publications

References 6 publications

Sclerotherapy of Intraoral Superficial Hemangioma

Sclerotherapy of Intraoral Superficial Hemangioma

Role of Polidocanol as Sclerosant in Treatment of Hemangiomas of Head and Neck Region

Contact Info

Product

Resources

About